The Life of Hubert J.P. Schoemaker (1950-2006) : An Oral History
- 2006-Jun – 2007-Nov
This work tells the story of Hubert Schoemaker’s life. More than sixty friends, family members, and colleagues were interviewed about their interactions with Hubert, and snippets of their recollections have been combined to create a narrative that describes Hubert’s life from his birth in 1950 until his passing in 2006. The audio files of these interviews are maintained by the Center for Oral History. Individuals interested in reviewing one or more of these interviews should email oralhistory@sciencehistory.org.
Hubert Jacob Paul Schoemaker (March 1950–January 2006) was one of the first generation of biotechnology entrepreneurs. He was a cofounder of Centocor (established in 1979), the first company successfully to commercialize monoclonal antibodies for therapeutic purposes, and the founder of Neuronyx (established in 1999), the first company to manufacture stem cells on a large scale and thereby enable the development of stem-cell therapeutics. Hubert’s vision, mentorship, and guidance were instrumental in building a biotechnology community not only in southeastern Pennsylvania, but also nationally and internationally.
Access this interview
By request 1 PDF Transcript File
Fill out a brief form to receive immediate access to these files.
If you have any questions about transcripts, recordings, or usage permissions, contact the Center for Oral History at oralhistory@sciencehistory.org.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
| Property | Value |
|---|---|
| Editor | |
| Format | |
| Genre | |
| Extent |
|
| Language | |
| Subject | |
| Rights | Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License |
| Rights holder |
|
| Credit line |
|
About the Interviewers
Ted Everson, the director of clinical communications at Vital Issues in Medicine (VIM), a medical education company, earned a PhD in history and philosophy of science and technology from the University of Toronto and an MS in medical genetics from the University of British Columbia. During his tenure at CHF he founded the biotechnology program, which included focused scholarship on industry development. He is the author of The Gene: A Historical Perspective (2007), “Genetic Engineering Methods” in The Encyclopedia of Twentieth Century Technology (2004), and “Genetics and Molecular Biology” in History of the Exact Sciences and Mathematics (2002).
Lara Marks was educated at Sussex University and Oxford University, where she earned a doctorate in the history of medicine. Marks has held full-time research and teaching posts at Queen Mary College, London University; London School of Hygiene; and Tropical Medicine and Imperial College, London. She currently holds a visiting post at Cambridge University, and she is a senior research partner for Silico Research Limited, an independent organization that studies the life sciences industry. Marks’s publications include Sexual Chemistry: An International History of the Contraceptive Pill (2001) and “Assessing the Risk and Safety of the Pill: Maternal Mortality and the Pill,” a chapter in Risk and Safety in Medical Innovation (2006).
Institutional location
| Department | |
|---|---|
| Collection | |
| Oral history number | 0624 |
| Physical container |
|
Related Items
Interviewee biographical information
| Born |
|
|---|---|
| Died |
|
Cite as
See our FAQ page to learn how to cite an oral history.